| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 79, 1355-1360, Copyright © 1994 by Endocrine Society
ARTICLES |
HD Mason, DS Willis, RW Beard, RM Winston, R Margara and S Franks
Department of Obstetrics and Gynecology, St. Mary's Hospital Medical School, Imperial College of Science, Technology, and Medicine, London, United Kingdom.
The underlying cause of anovulation in polycystic ovary syndrome is unknown. Circulating levels of immuno- and bioactive FSH are within the normal range, and the follicles contain measurable levels of bioactive FSH. The aim of this study was to compare estradiol (E2) production in response to FSH by granulosa cells from normal ovaries with those from polycystic ovaries derived from both anovulatory (anovPCO) and ovulatory subjects (ovPCO). Intrafollicular levels of immunoactive FSH, E2, and androstenedione in follicles of less than 12 mm were also measured. Follicular fluid steroid concentrations were obtained from 41 pairs of normal ovaries and 23 pairs of polycystic ovaries (8 anovPCO and 15 ovPCO). In size-matched follicles from each group there were no significant differences in follicular fluid FSH or E2 concentrations, but androstenedione levels were significantly higher in 5- to 11-mm follicles from ovPCO than in corresponding follicles from normal ovaries. Dose responses to FSH were determined in granulosa cells derived from 9 pairs of normal ovaries, 7 anovPCO, and 8 ovPCO. Cells from anovPCO produced 6- to 10-fold more E2 in response to FSH than normal cells, although there was no significant difference in the ED50 values. The response in cells from ovPCO was reduced compared to normal, but this difference did not reach significance. In summary, as judged by their FSH and E2 contents, polycystic ovaries do not have a higher proportion of atretic follicles than normal. Indeed, cells from anovPCO are hyperesponsive to FSH in vitro. This could be explained by stimulation of aromatase in vivo by either paracrine or, more probably, by endocrine factors, of which insulin is an arguable candidate.
This article has been cited by other articles:
![]() |
M. J. Prodoehl, N. Hatzirodos, H. F. Irving-Rodgers, Z. Z. Zhao, J. N. Painter, T. E. Hickey, M. A. Gibson, W. E. Rainey, B. R. Carr, H. D. Mason, et al. Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries Mol. Hum. Reprod., December 1, 2009; 15(12): 829 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.H. Dickerson, L.W. Cho, S.D. Maguiness, S.L. Killick, J. Robinson, and S.L. Atkin Insulin resistance and free androgen index correlate with the outcome of controlled ovarian hyperstimulation in non-PCOS women undergoing IVF Hum. Reprod., November 17, 2009; (2009) dep393v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rice, L. Pellatt, K. Ramanathan, S. A. Whitehead, and H. D. Mason Metformin Inhibits Aromatase via an Extracellular Signal-Regulated Kinase-Mediated Pathway Endocrinology, October 1, 2009; 150(10): 4794 - 4801. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. BAKA, K. ZOURLA, A. MALAMITSI-PUCHNER, E. MAKRAKIS, G. KAPAROS, S. DEMERIDOU, T. MOUSTAKARIAS, D. TZANAKAKI, D. HASSIAKOS, and E. KOUSKOUNI Intrafollicular Levels of Matrix Metalloproteinases-2 and -9 in Patients with Polycystic Ovaries Are Not Associated with Pregnancy Rate During IVF Cycle In Vivo, January 1, 2009; 23(1): 89 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Catteau-Jonard, S. P. Jamin, A. Leclerc, J. Gonzales, D. Dewailly, and N. di Clemente Anti-Mullerian Hormone, Its Receptor, FSH Receptor, and Androgen Receptor Genes Are Overexpressed by Granulosa Cells from Stimulated Follicles in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4456 - 4461. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Franks, J. Stark, and K. Hardy Follicle dynamics and anovulation in polycystic ovary syndrome Hum. Reprod. Update, May 22, 2008; (2008) dmn015v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Sipe and B. J. Van Voorhis Testosterone patch improves ovarian follicular response to gonadotrophins in a patient with Kallmann's syndrome: A Case Report Hum. Reprod., May 1, 2007; 22(5): 1380 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wood, D. A. Dumesic, D. H. Abbott, and J. F. Strauss III Molecular Abnormalities in Oocytes from Women with Polycystic Ovary Syndrome Revealed by Microarray Analysis J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 705 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wu, S. Fujii, N.K. Ryan, K.H. Van der Hoek, M.J. Jasper, I. Sini, S.A. Robertson, R.L. Robker, and R.J. Norman Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome Hum. Reprod., February 1, 2007; 22(2): 527 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pellatt, L. Hanna, M. Brincat, R. Galea, H. Brain, S. Whitehead, and H. Mason Granulosa Cell Production of Anti-Mullerian Hormone Is Increased in Polycystic Ovaries J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 240 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Foong, D. H. Abbott, M. A. Zschunke, T. G. Lesnick, J. L. Phy, and D. A. Dumesic Follicle Luteinization in Hyperandrogenic Follicles of Polycystic Ovary Syndrome Patients Undergoing Gonadotropin Therapy for in Vitro Fertilization J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2327 - 2333. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, A. E. Taylor, J. Fox, G. M. Messerlian, J. M. Adams, and A. L. Schneyer Follicular Arrest in Polycystic Ovary Syndrome Is Associated with Deficient Inhibin A and B Biosynthesis J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5582 - 5587. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. R. Maciel, E. C. Baracat, J. A. Benda, S. M. Markham, K. Hensinger, R. J. Chang, and G. F. Erickson Stockpiling of Transitional and Classic Primary Follicles in Ovaries of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5321 - 5327. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Coffler, K. Patel, M. H. Dahan, P. J. Malcom, T. Kawashima, R. Deutsch, and R. J. Chang Evidence for Abnormal Granulosa Cell Responsiveness to Follicle-Stimulating Hormone in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1742 - 1747. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, A. E. Taylor, K. A. Martin, and J. E. Hall Serum Inhibin B in Polycystic Ovary Syndrome: Regulation by Insulin and Luteinizing Hormone J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5559 - 5565. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Wright, J. M.P. Holly, R. Galea, M. Brincat, and H. D. Mason Insulin-Like Growth Factor (IGF)-Independent Effects of IGF Binding Protein-4 on Human Granulosa Cell Steroidogenesis Biol Reprod, September 1, 2002; 67(3): 776 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.F. Lunn, H.M. Fraser, and H.D. Mason Structure of the corpus luteum in the ovulatory polycystic ovary Hum. Reprod., January 1, 2002; 17(1): 111 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Greisen, T. Ledet, and P. Ovesen Effects of androstenedione, insulin and luteinizing hormone on steroidogenesis in human granulosa luteal cells Hum. Reprod., October 1, 2001; 16(10): 2061 - 2065. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujiwara, Y. Sidis, C. Welt, G. Lambert-Messerlian, J. Fox, A. Taylor, and A. Schneyer Dynamics of Inhibin Subunit and Follistatin mRNA during Development of Normal and Polycystic Ovary Syndrome Follicles J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4206 - 4215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Elting, J. Kwee, R. Schats, L. T. M. Rekers-Mombarg, and J. Schoemaker The Rise of Estradiol and Inhibin B after Acute Stimulation with Follicle-Stimulating Hormone Predict the Follicle Cohort Size in Women with Polycystic Ovary Syndrome, Regularly Menstruating Women with Polycystic Ovaries, and Regularly Menstruating Women with Normal Ovaries J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1589 - 1595. [Abstract] [Full Text] |
||||
![]() |
C. K. Welt and A. L. Schneyer Differential Regulation of Inhibin B and Inhibin A by Follicle-Stimulating Hormone and Local Growth Factors in Human Granulosa Cells from Small Antral Follicles J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 330 - 336. [Abstract] [Full Text] |
||||
![]() |
M.P. Teissier, H. Chable, S. Paulhac, and Y. Aubard Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability Hum. Reprod., December 1, 2000; 15(12): 2471 - 2477. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gilling-Smith, H. Mason, D. Willis, S. Franks, and R.W. Beard In-vitro ovarian steroidogenesis in women with pelvic congestion Hum. Reprod., December 1, 2000; 15(12): 2570 - 2576. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.L. Mikkelsen, S. Smith, and S. Lindenberg Impact of oestradiol and inhibin A concentrations on pregnancy rate in in-vitro oocyte maturation Hum. Reprod., August 1, 2000; 15(8): 1685 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.P. Teissier, H. Chable, S. Paulhac, and Y. Aubard Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology Hum. Reprod., September 1, 1999; 14(9): 2236 - 2241. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Weil, K. Vendola, J. Zhou, and C. A. Bondy Androgen and Follicle-Stimulating Hormone Interactions in Primate Ovarian Follicle Development J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2951 - 2956. [Abstract] [Full Text] |
||||
![]() |
A. C. Cobo, A. Requena, F. Neuspiller, M. Aragones, A. Mercader, J. Navarro, C. Simon, J. Remohi, and A. Pellicer Maturation in vitro of human oocytes from unstimulated cycles: selection of the optimal day for ovum retrieval based on follicular size Hum. Reprod., July 1, 1999; 14(7): 1864 - 1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mendoza, N. Cremades, E. Ruiz-Requena, F. Martinez, E. Ortega, S. Bernabeu, and J. Tesarik Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations Hum. Reprod., March 1, 1999; 14(3): 628 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Misajon, P. Hutchinson, N. Lolatgis, A. O. Trounson, and G. Almahbobi The mechanism of action of epidermal growth factor and transforming growth factor {alpha} on aromatase activity in granulosa cells from polycystic ovaries Mol. Hum. Reprod., February 1, 1999; 5(2): 96 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Willis, H. Watson, H. D. Mason, R. Galea, M. Brincat, and S. Franks Premature Response to Luteinizing Hormone of Granulosa Cells from Anovulatory Women with Polycystic Ovary Syndrome: Relevance to Mechanism of Anovulation J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3984 - 3991. [Abstract] [Full Text] |
||||
![]() |
M. van der Meer, P. G. A. Hompes, J. A. M. de Boer, R. Schats, and J. Schoemaker Cohort Size Rather Than Follicle-Stimulating Hormone Threshold Level Determines Ovarian Sensitivity in Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 423 - 426. [Abstract] [Full Text] |
||||
![]() |
P. Pigny, R. Desailloud, C. Cortet-Rudelli, A. Duhamel, D. Deroubaix-Allard, A. Racadot, and D. Dewailly Serum {alpha}-Inhibin Levels in Polycystic Ovary Syndrome: Relationship to the Serum Androstenedione Level J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1939 - 1943. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Schipper, F. F. G. Rommerts, P. M. ten Hacken, and B. C. J. M. Fauser Low Levels of Follicle-Stimulating Hormone Receptor-Activation Inhibitors in Serum and Follicular Fluid from Normal Controls and Anovulatory Patients with or without Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1325 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. J. M. Fauser and A. M. van Heusden Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences Endocr. Rev., February 1, 1997; 18(1): 71 - 106. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |